White paper · CureLogic AI

The Cure

The cryptocurrency for personalised precision medicine — by Gwen Swan, CEO of CureLogic.

CURELOGIC AI · WHITE PAPER
The CURE
The Cryptocurrency for Personalized Precision Medicine
By Gwen Swan

Author: Gwen Swan, CEO of CureLogic
Published by the Catalyst Institute · gwen-swan.com

Abstract

The CURE is a decentralised cryptocurrency designed to power the CureLogic AI platform, enabling patients to access personalised precision miRNA-based drug treatment plans at a 50% discount when purchased in advance. Leveraging advanced AI and multi-omics data, CURE facilitates preventive medicine and disease-prevention insurance by making cutting-edge, individualised therapies accessible and affordable. The token is issued and managed by CureLogic AI, with an unlimited supply model to ensure broad accessibility.

Get your free e-book

Download the CURE white paper

The token

CURE — the financial backbone

CURE is an ERC-20-compatible token, interoperable with the Ethereum ecosystem and EVM-compatible chains. Smart contracts enforce transparent payment flows for treatment purchases and insurance, with minting and burning for supply management.

Token at a glance

Symbol

CUR

Standard

ERC-20

Decimals

18

Supply model

Unlimited

Initial issuance

1 Quadrillion

White paper

Read the full document

Chronic and complex diseases are increasingly recognised as deeply personal, driven by unique genetic, molecular, and environmental factors. CureLogic AI addresses this by generating individualised, miRNA-based drug signatures for each patient, using a proprietary AI platform that integrates genomics, proteomics, blood chemistry, and environmental data. CURE, the native cryptocurrency of CureLogic AI, is the payment and incentive mechanism for this ecosystem — offering patients and insurers a new paradigm in preventive and precision medicine.

Healthcare costs are rising, and most treatments are reactive rather than preventive. Existing insurance models do not incentivise early, personalised intervention. Access to truly individualised therapies is limited by cost, data complexity, and lack of scalable payment infrastructure. There is a need for a transparent, decentralised, and incentive-aligned system that empowers patients to access and pre-purchase precision medicine for disease prevention and early intervention.

CURE is a decentralised, blockchain-based cryptocurrency that enables:

  • Advance purchase of treatment plans — patients pre-purchase personalised precision-medicine signature drug-treatment plans at a 50% discount, securing future access at a lower cost.
  • Disease-prevention insurance — CURE serves as a payment mechanism for insurance-style preventive medicine, letting individuals and organisations hedge against future health risks.
  • Transparent, auditable payments — all transactions are recorded on-chain, ensuring transparency and trust.
  • AI-powered personalisation — payments in CURE unlock CureLogic AI’s diagnostic and drug-matching capabilities, analysing 10–30 key molecules across 55 million microRNA strains and matching them to optimal treatments from a 25 million drug repository.

Blockchain: CURE is an ERC-20-compatible token, ensuring interoperability with the Ethereum ecosystem and EVM-compatible chains.

Token details: Symbol CUR · Decimals 18 · Initial issuance 1 Quadrillion (1,000,000,000,000,000) · Supply model unlimited (mintable as needed for liquidity and accessibility) · Managed by CureLogic AI, with smart contracts enforcing transparency and security.

Smart-contract features: minting and burning for supply management; transparent payment flows for treatment purchases and insurance; integration with CureLogic AI’s diagnostic and treatment-recommendation engine.

Utility: CUR is used exclusively to pay for personalised precision-medicine plans generated by CureLogic AI.

Discount mechanism: advance purchases using CUR receive a 50% discount, incentivising proactive health management.

Access and distribution: CUR is available to patients, insurers, and healthcare providers globally; unlimited supply ensures no barriers to entry.

Governance: CureLogic AI manages issuance and protocol upgrades, with a roadmap toward increased community governance as adoption scales.

  • Personalised precision medicine — individualised drug regimens based on deep molecular analysis, not generic therapies.
  • AI-driven matching — proprietary algorithms analyse up to 30 molecules from 55 million microRNA strains, matching each patient to a unique treatment from a 25 million-compound library.
  • Preventive focus — CUR enables advance payment and insurance models, shifting healthcare from reactive to proactive.
  • Decentralised payments — blockchain ensures transparency, auditability, and security.
  • Q3 2025: token deployment, CureLogic AI platform integration, pilot with select clinics and insurers.
  • Q4 2025: global rollout, partnerships with healthcare providers and insurers, DAO governance framework development.
  • 2026 and beyond: expansion of AI capabilities, integration with additional omics data sources, scaling of preventive insurance products.

CureLogic AI is led by a multidisciplinary team of experts in artificial intelligence, genomics, blockchain, and clinical medicine — committed to transforming healthcare through precision and prevention.

The CURE is more than a cryptocurrency: it is the financial backbone of a new healthcare paradigm, empowering patients to access and afford the most advanced personalised treatments available. By combining AI, blockchain, and multi-omics, CureLogic AI and CUR are setting a new standard for preventive, precision medicine.